Finnish and Nordic Lung Cancer Insights – January Update
This overview summarises Finnish and Nordic lung cancer research. Finnish studies focus on real-world metastatic NSCLC treatment patterns and outcomes, and the impact of concurrent medications on survival. Nordic studies address treatment selection and outcomes, prognostic biomarkers, diagnostic pathways, brain metastasis detection, cancer mortality disparities, patient-reported outcomes after radiotherapy, population-level prevention, socioeconomic differences, and clinicians’ views on LDCT screening.
